Gene Query: MLLT10

Dataset Description Geneva Score
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 40.26
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 39.95
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 30.06
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 19.31
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 17.46
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 16.95
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 16.66
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 16.29
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 14.55
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 14.21
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 14.16
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 13.29
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 13.09
Human HAP1 cells before and after nutrient deprivation 13.09
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 12.79
RNA-seq analysis to identify the genes regulated by p53-SET interplay 12.1
Knockdown of ADNP in HCT116 colon cancer cells 12.09
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 11.94
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 11.94
Gene expression profile of human iPSC-derived nephron progenitor cells 11.32
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 11.32
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 11.32
NRDE2 negatively regulates nuclear exosome functions 10.72
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 10.64
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 10.64
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.41
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.28
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 10.12
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.0
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 9.9
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 9.83
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 9.72
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 9.71
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 9.64
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 9.62
Targeted enhancer activation by a subunit of the integrator complex 9.32
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 9.28
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 9.23
LINE-2 transposable elements are a source of functional human microRNAs and target sites 9.17
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 9.06
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.02
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.01
Human embryonic stem cells in E8 and AKIT culture medium 9.01
Stem and effector CD8 T-cells from human cancers 8.94
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 8.74
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.68
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 8.63
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 8.63
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.43
Gene expression changes caused by KRAS in MCF-10A 8.27
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.18
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 7.52
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.51
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.5
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 7.43
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.4
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.21
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.21
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.2
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 7.03
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 7.03
The conserved transcriptional landscapes in human spermatogenesis 6.99
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 6.98
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 6.91
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 6.83
Genes significantly down or Up-regulated upon RNF219 knockdown 6.79
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.78
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 6.78
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.76
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 6.76
Transcriptome analysis in Neobractatin treated cells 6.72
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 6.59
Gene expression analysis of dengue-infected cells 6.46
RNA-seq analysis of differentiating human erythroblasts 6.41
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.37
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 6.35
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 6.33
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 6.32
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 6.31
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 6.29
Survival of pancreatic cancer cells lacking KRAS function 6.29
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.27
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.2
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 6.19
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.09
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.06
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.01
Effect of drugs on transcriptomic profiles 5.97
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.95
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.95
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.89
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 5.88
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 5.84
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.82
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.82
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.82
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 5.79
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.76
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.75
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.73
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.72
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.72
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 5.69
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.69
SLIGRL-induced gene expression changes in NHEK cells 5.69
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 5.68
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 5.68
Gene expression profiling of leukemia cells following asparagine depletion 5.63
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 5.6
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 5.58
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 5.58
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 5.57
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.56
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.56
TCF7L1 knockdown in pancreatic cancer 5.52
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.52
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.52
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.5
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.48
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.48
Capturing the Interactome of Newly Transcribed RNA 5.48
Genome-wide discovery of human splicing branchpoints 5.47
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.44
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.44
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 5.43
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.43
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 5.42
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 5.42
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.41
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.4
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 5.4
Developmental stage specific chromosome architecture in human erythroid cells 5.37
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.37
hTERT promotes cell adhesion and migration independent of telomerase activity 5.36
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 5.33
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 5.32
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.31
IMP3 regulated gene expression in breast cancer cells 5.28
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.28
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.25
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 5.25
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 5.24
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 5.23
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.22
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.22
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.16
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.14
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.12
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.12
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.09
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 5.09
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.08
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 5.08
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 5.08
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.06
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 5.05
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.04
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 5.03
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.01
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 5.0
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.94
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 4.94
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 4.89
Gene expression in GBM with Cav3.2 inhibition 4.89
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 4.85
Uridylation by TUT4 and TUT7 marks mRNA for degradation 4.85
RNA-sequencing of human tendon after injury 4.84
Transcriptomic analyssis following EHMT1/2 inhibition 4.82
High-throughput sequencing of PROMPT-enriched samples. 4.8
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 4.76
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.75
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.75
Transcriptome sequencing of K-562 cells 4.71
Mapping interactions for the TNIP2 hub protein 4.7
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.7
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.65
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.64
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.64
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.64
Targeting MTHFD2 in Acute Myeloid Leukemia 4.63
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 4.62
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 4.62
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.57
EP400 is required for Max and MCPyV mediated gene activation 4.57
Active translatome profiling with RiboLace in MCF7 cells 4.55
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 4.53
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 4.53
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.53
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 4.53
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 4.52
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.5
Genome wide expression change in LCC2 and MCF-7 cells 4.49
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 4.44
Functional role of CPPED1 in trophoblasts. 4.44
Differetially expressed genes after hTR overexpression in U2OS cells 4.44
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.42
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 4.4
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 4.39
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.39
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.33
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.33
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.32
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.32
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 4.29
Depicting early human development and germ cell origin with porcine embryos 4.29
Cerebellar differentiation in Ataxia-Telangiectasia 4.29
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 4.29
Tracking of dCas9-methyltransferase footprints 4.29
DJ-1 is dispensable for human stem cell homeostasis 4.26
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.25
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.24
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 4.24
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.24
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 4.21
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.21
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.17
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.17
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.16
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 4.16
Universal alternative splicing of noncoding exons 4.16
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 4.16
N6-methyladenine DNA Modification in Glioblastoma 4.16
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.16
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.14
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 4.14
PRDM1 inhibits proliferation of human colon cancer organoids 4.12
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 4.12
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.07
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.07
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.06
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.05
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.03
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.03
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.03
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.03
Genome-wide mapping of TEL-AML1 targets in acute leukemia 4.0
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.0
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.0
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.96
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.93
Non-coding regions are the main source of tumor-specific antigens 3.88
Non-coding regions are the main source of tumor-specific antigens [human] 3.88
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 3.84
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.76
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 3.74
Changes in human endometrial gland transcriptome over the window of implantation 3.73
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 3.73
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 3.72
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.72
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.72
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.72
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.71
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 3.69
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 3.69
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.69
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.64
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.63
Illumina Total RNA-seq in HeLa 3.61
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.61
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 3.6
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.59
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.59
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 3.53
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 3.51
mRNA recovered upon RNF219 IP. [RNA-IP] 3.49
Biological effect of chronic mistranslation in mammalian cells 3.45
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.44
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.44
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 3.43
3.42
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 3.4
Gene expressions of H9s in different culture systems 3.39
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.38
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.38
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.34
RNA Sequencing of Human iPS derived Cardiomyocytes 3.33
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 3.33
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.27
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.26
Transcriptome analysis of CNS leukemia 3.26
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.26
K562 polyA RNA-Seq 3.25
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.24
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 3.23
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 3.21
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 3.2
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 3.19
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 3.19
Effect of from Human Umbilical Vein Endothelial Cells 3.19
Co-regulation of splicing by Rbfox1 and hnRNP M 3.18
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.18
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 3.13
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 3.13
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.09
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.05
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.05
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.04
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.03
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.03
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.99
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 2.99
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.98
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 2.97
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 2.96
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.95
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.94
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.93
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.93
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.91
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.91
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.89
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.88
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.85
RNA sequencing of T-ALL (COG study) 2.76
Analyses of T-ALL (COG study) 2.76
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.76
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.75
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 2.74
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.7
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.7
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.69
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.64
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.61
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.59
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.57
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.57
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.56
Seletive inhibition of CDK9 in DLBCL cell lines 2.52
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.52
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 2.47
Regulation of poly(A) tail and translation during the somatic cell cycle 2.45
Identification of Atrial Fibrillation associated genes and functional non-coding variants 2.45
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.43
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 2.42
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.41
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.37
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.36
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 2.35
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.34
Recovery and analysis of nascent RNA 2.32
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.32
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.29
scRNASeq analysis of cycling cardiomyocytes 2.27
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.26
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.22
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 2.21
Controlling for gene expression changes in transcription factor protein networks. 2.17
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 2.15
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.04
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.03
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 2.03
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 2.0
The transcriptome and chromatin accessbility landscape of mammalian germline 1.96
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.95
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.94
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 1.92
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.91
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.89
Transcriptional landscape changes during human embryonic stem cell derivation 1.89
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.88
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.88
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.87
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.87
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.83
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.82
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.8
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.79
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.73
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.72
Gene expression analysis of human hepatocellular cancers 1.71
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.69
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.69
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.68
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.65
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.64
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.64
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.56
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 1.55
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 1.55
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.53
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.53
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.51
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.48
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.48
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.45
The transcriptome effect of overexpressing EZH2 in MCF7 1.44
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.39
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.37
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.37
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.37
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.36
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.36
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.33
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.33
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.33
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.32
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.27
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.24
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.24
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.24
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.23
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.21
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.21
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.21
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.2
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.2
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 1.18
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.16
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.15
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.12
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.09
Microglia innatly develop within cerebral organoids 1.08
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.04
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.02
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.01
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.0
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.99
Transcriptomes in healthy and CHB fetal hearts 0.98
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 0.97
Interaction between mitoNEET and NAF-1 in cancer cells 0.96
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.95
RNAseq analysis of ruxolitinib treated breast cancers 0.94
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.93
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.92
The circadian transcriptional landscape in primary human mammary epithelial cells 0.9
RNA-Seq in PWS iPSC-derived neurons 0.9
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.89
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.85
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.85
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.85
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.85
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.84
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.83
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.81
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.81
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.8
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.78
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.78
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.76
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.73
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.73
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.72
RNA-seq of primary patient AML samples 0.64
Transcriptome analysis of peripheral blood monocytes 0.63
Function and hormonal regulation of GATA3 in human first trimester placentation 0.61
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.6
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.6
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.6
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.6
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.58
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.57
RNA-seq analysis upon ARID1B overexpression 0.57
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.55
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.5
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.49
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.47
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.43
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.42
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.4
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.39
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.39
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.38
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.35
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.34
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.32
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.32
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.3
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.26
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.26
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.25
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.25
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.23
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.22
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.22
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.22
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.22
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.2
Leucegene: AML sequencing (part 6) 0.17
RNA-seq analysis of control and Myc-induced U2OS cells 0.16
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.16
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.16
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.16
Ribosomal protein RPL26 is the principal target of UFMylation 0.15
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.14
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.14
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.14
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.13
Aging-associated patterns in the expression of human endogenous retroviruses 0.13
Modulation of nonsense-mediated decay by rapamycin 0.12
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.12
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.12
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.09
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.07
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.07
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.02
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.0
4sU-seq of HFF exposed to salt and heat stress 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation